Animation and Consumer Perceptions of DTC Pharmaceutical Advertisement

The Food and Drug Administration (FDA) has noted that animation within direct-to-consumer (DTC) pharmaceutical advertising may impact perceptions of risk or benefit, and that there have been few if any comprehensives studies of the impact animation may exert upon consumers. This article proposes tha...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of consumer affairs 2019-12, Vol.53 (4), p.1456-1477
Main Authors: SHAH, ESTA D., LARSON, LINDSAY R. L., DENTON, LUTHER L.
Format: Article
Language:English
Subjects:
Advertising
Animation
Consumer protection
Consumer Well-being and Marketing Communications
Consumers
Food consumption
Pharmaceutical industry
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Food and Drug Administration (FDA) has noted that animation within direct-to-consumer (DTC) pharmaceutical advertising may impact perceptions of risk or benefit, and that there have been few if any comprehensives studies of the impact animation may exert upon consumers. This article proposes that the use of animation in pharmaceutical advertising potentially disrupts the encoding process in the mind of the consumer, impacting perceptions of prescription drug benefits and risks. Using novel stimuli employing a rotoscoping technique, it is found that animation significantly reduces perceptions of perceived risk (but not benefits), and that this effect is driven by disruptions in encoding (Study 1). These findings are extended to examine deeper consumer inferences (Study 2). Implications for the pharmaceutical industry, consumer protection agencies, and consumers are considered.
ISSN:0022-0078
1745-6606
DOI:10.1111/joca.12249